Results The 3-year survival rate was better in patients without giant tumor bulk than that with giant tumor bulk(P<0.01).
结果巨大肿块组3年生存率明显好于无巨大肿块组（P<0.01）；
Objective Retrospectively analyzed the 3-year survival rate and the factors of low-grade glioma treated by postoperative radiotherapy.
目的回顾性分析低分级脑胶质瘤术后放疗的3年生存率及其影响因素。
RESULTS: The candidates' overall 3-year survival rate and recurrence-free survival rate were 67% and 70% after transplantation, respectively.
结果：在移植后，候选人全部3年存活率和无肿瘤复发存活率分别为67％、70％。
The observation indexes: after hospitalization, follow-up and comparison of 3-year survival rate fron the date of hospitalization admission between the two groups.
观察指标：入院治疗后，随访比较两组病人自入院日算起3年的存活率。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
Objective: To observe the short-term curative effects, the survival rate of 3-year and the acute adverse effects of paclitaxel capsule combined with radiotherapy for advanced nasopharyngeal carcinoma.
目的：观察晚期鼻咽癌放疗并紫杉醇胶囊口服化疗的近期疗效、3年生存率及急性不良反应。
The 5 year survival rate was 55 3% in patients with signet ring cell carcinoma after curative operation, which was higher than that in other types of gastric cancer (41 8%, P< 0 05).
在腹膜及肝转移复发等方面与其他类型胃癌无差异。 行根治性手术后5年生存率为5 5 3% ，高于其他组织学类型胃癌（41 8% ） （P<0 0 5 ）。
The 3 year survival rate for radical resection group was 61 1% and higher than that of 18 2% for palliative excision group( P< 0 01).
根治手术病例3年生存率为6 1 1% ，姑息手术病例3年生存率为18 2 % ，两组比较差异有非常显著性意义（P< 0 0 1）。
The follow-up was 3-43 month after the operation. The one year and three years survival rate were 98% (47/48) and 91% (20/22) .
术后随访时间3-43个月，1、3年生存率分别为98%（47/48）和91%（20/22），2例患者局部复发，2例患者肝转移，术后因肿瘤转移死亡2例，失访3例；
The follow-up was 3-43 month after the operation. The one year and three years survival rate were 98% (47/48) and 91% (20/22) .
术后随访时间3-43个月，1、3年生存率分别为98%（47/48）和91%（20/22），2例患者局部复发，2例患者肝转移，术后因肿瘤转移死亡2例，失访3例；
应用推荐